15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 22 firms covering DexCom Inc, 19 rate it Buy or better, 2 sit at Hold, and 1 rate it Sell or worse, a strong buy consensus. Targets span $64.00 to $96.00, a moderate spread. The average target of $88.65 sits 5% above the current $84.52. The rating mix has stayed broadly stable, with Buy-side ratings easing from 20 to 18 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.73 next quarter toward $3.12 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS22 ratings
Strong Buy
Strong Buy00%
Buy1986%
Hold29%
Sell15%
Strong Sell00%
Based on 22 analysts giving stock ratings to DexCom Inc.
As of Sep, 18 of 21 firms rate DXCM a Buy (2 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
DXCM EPS & revenue forecast
EPS · NEXT QUARTER
$0.73
Range $0.70 – $0.77 · 21 analysts · +8% YoY
Next period, 21 analysts expect DexCom Inc to earn $0.73 a share (range $0.70 – $0.77), versus $0.68 a year earlier. Full-year consensus is $2.66, growing to $3.12 the year after.
REVENUE · NEXT QUARTER
$1.4B
Range $1.4B – $1.4B · 21 analysts · +11% YoY
Revenue is expected to reach $1.4B (range $1.4B – $1.4B), +11.2% year-over-year. Full-year consensus is $5.2B, rising to $5.8B next year.
Top analysts covering DexCom Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DXCM.
#1
Anthony Petrone
Mizuho · Rank #86
Buy
$95.00+12.4% to target
Overall win rate
46%
+ Follow
#2
JB
Jayson Bedford
Raymond James · Rank #196
Buy
$94.00+11.2% to target
Overall win rate
42%
+ Follow
#3
Jonathan Block
Stifel · Rank #205
Buy
$95.00+12.4% to target
Overall win rate
41%
+ Follow
#4
William Plovanic
Canaccord Genuity · Rank #243
Buy
$90.00+6.5% to target
Overall win rate
37%
+ Follow
#5
Bruce Jackson
Benchmark · Rank #374
Buy
$82.00-3.0% to target
Overall win rate
36%
+ Follow
DXCM stock forecast FAQ
What is DXCM's average 12-month price target?+
The 17 analysts with a live target average $88.65 for DexCom Inc over the next 12 months, ranging from a $96.00 high to a $64.00 low.
Is DXCM stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 22 analyst ratings, 19 are Buy or Strong Buy, 2 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for DXCM?+
The Street-high target is $96.00 (Argus Research), and the Street-low is $64.00 (Barclays). The average of all 17 active targets is $88.65.
How many Wall Street analysts cover DXCM?+
22 analysts have an active rating on DexCom Inc, and 17 firms carry a live 12-month price target.
Who is the most accurate analyst covering DXCM?+
Among analysts who currently cover DXCM, Anthony Petrone of Mizuho has the strongest overall Quantellect track record (Rank #86). Their current call is Buy with a $95.00 target.
What is DexCom Inc's projected EPS for next quarter?+
The consensus estimate is $0.73 per share (range $0.70 – $0.77) across 21 analysts. Full-year EPS is projected at $2.66, rising to $3.12 the following year.
How much revenue is DexCom Inc expected to report next quarter?+
Consensus revenue is $1.4B (range $1.4B – $1.4B). Full-year revenue is projected at $5.2B, growing to $5.8B next year.
Have analysts been upgrading or downgrading DXCM lately?+
As of Sep, 18 of 21 firms rate DXCM a Buy (2 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DXCM calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
RBC Capital
UBS
Deutsche Bank
